Tricida Depreciation & Amortization 2011-2025 | TCDA

Annual Depreciation & Amortization Tricida

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
442 K	897 K	757 K	618 K	335 K	424 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
897 K	335 K	579 K

Quarterly Depreciation & Amortization Tricida

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	231 K	158 K	81 K	-	351 K	253 K	134 K	-	200 K	200 K	230 K	-	200 K	200 K	172 K	-	200 K	100 K	138 K	-	100 K	100 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
351 K	81 K	179 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.21	-7.63 %	$ 130 M	Canada
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	125 M	$ 12.36	-2.37 %	$ 633 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	$ 21.6	0.07 %	$ 2.06 B	France
Evolus EOLS	5.3 M	$ 6.88	0.36 %	$ 427 M	USA
Harrow Health HROW	1.06 M	$ 50.08	-0.16 %	$ 1.63 B	USA
China Pharma Holdings CPHI	2.62 M	$ 1.29	-1.56 %	$ 22.5 M	China
Organogenesis Holdings ORGO	13.6 M	$ 5.36	-8.71 %	$ 706 M	USA
Bausch Health Companies BHC	1.26 B	$ 7.19	-0.07 %	$ 2.62 B	Canada
Pacira BioSciences PCRX	78.8 M	$ 26.48	1.77 %	$ 1.22 B	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Cumberland Pharmaceuticals CPIX	4.9 M	$ 4.11	-2.14 %	$ 57.8 M	USA
Rockwell Medical RMTI	1.44 M	$ 0.87	7.18 %	$ 20.3 M	USA
Solid Biosciences SLDB	2.46 M	$ 5.83	-1.19 %	$ 238 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 3.63	-0.41 %	$ 4.5 M	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Veru VERU	268 K	$ 2.37	1.28 %	$ 320 M	USA
Perrigo Company plc PRGO	326 M	$ 13.87	0.95 %	$ 1.91 B	USA
ProPhase Labs PRPH	4.72 M	$ 0.51	-16.94 %	$ 8.08 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 4.5	-2.21 %	$ 135 M	USA
cbdMD YCBD	452 K	$ 1.69	3.68 %	$ 7.29 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	28.2 M	$ 9.92	0.22 %	$ 705 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	580 K	$ 0.58	-1.87 %	$ 27.8 M	USA
Tilray TLRY	35.7 M	$ 9.6	-5.43 %	$ 5.93 B	Canada
TherapeuticsMD TXMD	922 K	$ 1.72	0.88 %	$ 18 M	USA
Viatris VTRS	3.03 B	$ 12.33	0.69 %	$ 14.9 B	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA